Offer - Urjas Oil for just ₹ 1
Hepacure Pn (Tasmed) is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Hepacure Pn (Tasmed) have also been mentioned below.
The optimal dosage of Hepacure Pn (Tasmed) is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Hepacure Pn (Tasmed) are Nausea or vomiting, Stomach ache, Bloating or fullness. Usually, these side effects of Hepacure Pn (Tasmed) go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Hepacure Pn (Tasmed) has a Not Used By Women effect for pregnant women and Unknown effect on lactating mothers. In addition, Hepacure Pn (Tasmed)'s effects on the liver, heart and kidney are discussed below in the Hepacure Pn (Tasmed) related warnings section.
Hepacure Pn (Tasmed) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Allergy are examples of such conditions.
Additionally, Hepacure Pn (Tasmed) may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Hepacure Pn (Tasmed) is considered not safe while driving, and is not addictive.
Hepacure Pn (Tasmed) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Hepacure Pn (Tasmed) safe for pregnant women?
Not Used by Women
Is the use of Hepacure Pn (Tasmed) safe during breastfeeding?
There is no research available on the side effects of Hepacure Pn (Tasmed) in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Hepacure Pn (Tasmed) on the Kidneys?
Hepacure Pn (Tasmed) can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Hepacure Pn (Tasmed) on the Liver?
The liver can be affected by Hepacure Pn (Tasmed). If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Hepacure Pn (Tasmed) only after medical advice.
What is the effect of Hepacure Pn (Tasmed) on the Heart?
Hepacure Pn (Tasmed) may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Hepacure Pn (Tasmed) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Hepacure Pn (Tasmed) unless your doctor advises you to do so -
Is this Hepacure Pn (Tasmed) habit forming or addictive?
Hepacure Pn (Tasmed) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Hepacure Pn (Tasmed). So it is best to avoid driving.
Is it safe?
Hepacure Pn (Tasmed) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Hepacure Pn (Tasmed) is not used to treat mental disorders.
Interaction between Food and Hepacure Pn (Tasmed)
Due to a lack of research, nothing can be said about the consequences of taking Hepacure Pn (Tasmed) together with food.
Interaction between Alcohol and Hepacure Pn (Tasmed)
It is difficult to say anything about the effect of Hepacure Pn (Tasmed) and alcohol. No research has been done on this yet.
No, Hepacure Pn (Tasmed) does not cause weight loss, weight loss has not been associated with this drug. However, if you are experiencing unusual weight loss and you are in doubt that Hepacure Pn (Tasmed) is causing weight loss then discuss with your doctor instantly.
Hepacure Pn (Tasmed) contains L-ornithine l-aspartate which is a hepatoprotective agent. It works by promoting the synthesis of glutamine in our body which is an amino acid that binds with ammonia. This binding results in the formation of a complex which is non-toxic in nature and it is easily removed from the body by kidneys in urine. Normally, liver maintains the normal levels of ammonia in our body but to due liver damage caused by any medical condition affects this function which results in high levels of ammonia in our body (hyperammonemia ). These high levels of ammonia are harmful for our body which causes complications such as hepatic encephalopathy. Thus Hepacure Pn (Tasmed) helps in inactivation or detoxification and removal of these harmful excessive levels of ammonia which restores its balance in our body.
Yes, Hepacure Pn (Tasmed) causes nausea and vomiting, but this occurs in a few cases only. It is a rare side effect of this drug. For relief from nausea and vomiting try to take lime water, avoid eating spicy food even if it persists or becomes severe then discuss it with your doctor.
No, Hepacure Pn (Tasmed) is not a steroid. It is a hepatoprotective agent which is used in the management of hyperammonemia (high levels of ammonia in the blood) that results from liver diseases.
No, Hepacure Pn (Tasmed) is a prescription drug so do not take it without consulting a doctor. It can cause unpleasant effects for the patient to take this medicine without a doctor's recommendation. Hence, the patient should seek doctors advice before taking this medication by himself or herself.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Creon (pancrelipase)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 670